Portfolio Co Investors 2026 for Yuanbio Venture Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Yuanbio Venture Capital accounts for 5 tracked companies with verified cap-table data, 5 of which disclose round sizes totalling $239M. The median disclosed raise is $45M, and the largest is Allink Biotherapeutics at $89M, ahead of Excalipoint Therapetics ($69M) and Enzymaster ($45M).
The names that recur most often on these co-invested cap tables are Yuanbio Venture Capital (5 companies), Med-Fine Capital (3 companies), 5Y Capital (2 companies), Lanchi Ventures (1 company), Legend Capital (1 company), C&D Emerging Industry Equity Investment (1 company). By latest disclosed round, the market skews Series A (3), Seed (1), Series C (1).